Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

A Contract Award Notice
by UNITED LINCOLNSHIRE TEACHING HOSPITALS NHS TRUST

Source
Contracts Finder
Type
Contract (Products)
Duration
1 year
Value
£106K
Sector
HEALTH
Published
24 Jan 2025
Delivery
01 Jan 2025 to 31 Dec 2025
Deadline
16 Dec 2024 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo.

Award Detail

1 Bayer Public (Reading)
  • Value: £105,600

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

Reference

Domains